Month: February 2022
-
University Lab Licenses Printed Kidney Tissue Process
A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure.
-
Synthetic SARS-CoV-2 Particle Designed for Drug R&D
Two biotechnology companies created a synthetic non-infectious target model to represent SARS-CoV-2 viral variants for vaccine and therapy developers.
-
Infographic – Climate Investments Skyrocket in 2021
Venture investments in 2021 more than quadrupled from 2020 to nearly $9.3 billion, in companies developing technologies addressing the climate crisis.
-
Alzheimer’s Vaccine Shown to Produce Immune Response
In tests with lab animals, an experimental vaccine is shown to generate antibodies responding to toxic brain proteins associated with Alzheimer’s disease.
-
Start-Ups Partner on Quantum Computing and Longevity
Two companies formed in the last two years are applying quantum computing and artificial intelligence to discover new treatments for improving human longevity.
-
Health Breakthrough Research Group Doubles Funding
A not-for-profit organization that sponsors accelerated and high-impact health research worldwide says it gained a new $335 million in funding.
-
Precision Cancer Genomics Company Adds $23M in Early Funds
Biofidelity says its process simplifies detection of genetic indicators in tumors enabling more precise therapies for cancer patients.